At 7.5% CAGR, Global Immunohistochemistry (IHC) Market to Surpass US$ 3,348.7 Million by 2028, Says Coherent Market Insights (CMI)

Pune, INDIA


SEATTLE, Dec. 21, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global immunohistochemistry (IHC) market is estimated to be valued at US$ 2,020.2 Million in 2021 and is expected to exhibit a CAGR of 7.5% over the forecast period (2021-2028).

Key Trends and Analysis of the Global Immunohistochemistry (IHC) Market:

The increasing launch of novel immunohistochemistry (IHC) products by major players is expected to drive the growth of the global immunohistochemistry (IHC) market. For instance, in September 2019, Biocare Medical, LLC, a leading supplier and developer of primary antibodies and automated IHC medical equipment, launched p16 INK4a, which is a novel mouse monoclonal antibody that is intended for the qualitative detection of the p16 INK4a protein by IHC in formalin-fixed paraffin-embedded (FFPE) human tissues.

Furthermore, key players operating in the global immunohistochemistry (IHC) market are focusing on adoption of inorganic growth strategies such as collaborations to increase their market presence in the global market. For instance, in May 2018, F. Hoffmann-La Roche AG, a Swiss multinational healthcare company, collaborated with Five Prime Therapeutics, Inc., a clinical stage biotechnology company, to provide IHC companion diagnostic assays for use with Five Prime’s, bemarituzumab, which is an investigational anti-FGFR2b antibody.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4795

Key Market Takeaways:

The global immunohistochemistry (IHC) market is expected to exhibit a CAGR of 7.5% during the forecast period, owing to the product development and product upgradation by key players to strengthen their market position. For instance, in March 2018, Danaher Corporation's wholly-owned subsidiary Leica Biosystems (based in Germany) released an upgraded version of its BOND-III IHC and ISH stainer. The ease-of-use of both the instrument’s hardware and software has been improved with the newly released innovative version of the BOND-III.

Among end user, hospitals segment is expected to account for the largest share in the global immunohistochemistry (IHC) market in the forecast period, owing to the increasing number of specialized diagnostic tests in hospital laboratories, increasing number of in-house diagnostic procedures in hospitals.

Competitive Landscape:

Key players operating in the global immunohistochemistry (IHC) market include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Agilent Technologies, Inc., Abcam plc., Becton, Dickinson and Company, Takara Bio, Inc., Eagle Biosciences, Inc., Biocare Medical, LLC, Biogenex Laboratories, Diagnostic Biosystems, Inc., and BioVision Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4795

Market Segmentation:

  • Global Immunohistochemistry (IHC) Market, By Product:
    • Antibodies
      • Primary Antibodies
      • Secondary Antibodies
    • Equipment
      • Slide Staining Systems
      • Tissue Microarrays
      • Tissue Processing Systems
      • Slide Scanners
      • Others
    • Reagents
      • Histological Stains
      • Blocking Sera and Reagents
      • Chromogenic Substrates
      • Fixation Reagents
      • Stabilizers
      • Others
    • Kits
  • Global Immunohistochemistry (IHC) Market, By Application:
    • Diagnostics
      • Cancer
      • Infectious Diseases
      • Cardiovascular Diseases
      • Autoimmune Diseases
      • Diabetes Mellitus
      • Others
    • Drug Testing
    • Forensic Applications
  • Global Immunohistochemistry (IHC) Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Research Institutes
    • Others
  • Global Immunohistochemistry (IHC) Market, By Region:             
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France 
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

Immunomodulators Market, by Product Type (Immunosuppressants (Calcineurin Inhibitors, Glucocorticoids, Antimetabolites, and Others), Immunostimulants (Vaccines, Antibodies, and Others)), by Application (Oncology, Respiratory, HIV, and Others), by End User (Hospitals, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Antibody Drug Conjugates Market, by Drug Name (Adcetris, Kadcyla, Besponsa, Lumoxiti, Mylotarg, and Others), by Application (Blood Cancer, Breast Cancer, Urothelial & Bladder Cancer, and Other Types of Cancer), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028


About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedInTwitter

 

Coordonnées